Human Reproductive Technologies Market | Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Human Reproductive Technologies Market | Coherent Market Insights

Description:

Read here the latest updates on the Human Reproductive Technologies Market published by CMI team. – PowerPoint PPT presentation

Number of Views:18

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Human Reproductive Technologies Market | Coherent Market Insights


1
Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • Covid-19 Impact Tracker

2
  • HUMAN REPRODUCTIVE TECHNOLOGIES MARKET ANALYSIS
  • Human Reproductive Technologies Market, By
    Technology (Infertility Drugs, Contraceptive
    Drugs and Devices), and By Region (North America,
    Latin America, Europe, Asia Pacific, Middle East
    Africa) - Size, Share, Outlook, and Opportunity
    Analysis, 2020 - 2027

3
  • Human reproductive technologies include, Assisted
    Reproductive Technology (ART), prognostics,
    contraception, and same-sex procreation. ART aids
    in the treatment of low fertility or infertility
    using artificial insemination, artificial
    reproduction, cloning, cytoplasmic transfer,
    fertility medication, hormone treatment, and
    others.
  • The global human reproductive technologies market
    is estimated to account for US 28,426.7 Mn in
    2019 in terms of value and US 34,228.3 Mn by the
    end of 2027
  • Global Human Reproductive Technologies Market
    Drivers
  • Increasing prevalence of maternal mortality is
    expected to propel growth of the global human
    reproductive technologies market over the
    forecast period. For instance, according to
    Maternal Mortality 1990 to 2015 Estimates by
    WHO, UNICEF, UNFPA, World Bank Group and the
    United Nations Population Division, Sub-Saharan
    Africa recorded the highest ratio or maternal
    mortality, at 555 per 100, 000 live births, from
    1990 to 2015. Moreover, the United Nations is
    focused on achieving the Sustainable Development
    Goals 2015 - 2030 global maternal mortality ratio
    target of less than 70 per 100 000 live births.
  • Moreover, decreasing birth rate is also expected
    to aid in growth of the market. For instance,
    according to National Vital Statistics System,
    the provisional number of births for the U.S. in
    2018 was 3,788,235, registering a decrease of 2
    from 2017 and the lowest number of births in 32
    years.

4
  • Figure 1. Global Human Reproductive Technologies
    Market Share (), by Value, by Region, 2019

5
  • Global Human Reproductive Technologies Market
    Restraints
  • Limited insurance coverage for ART is expected to
    hinder growth of the market. ART is a relatively
    new and yet to be fully proven process in many
    countries. Such a status causes insurance
    companies to be apprehensive about covering
    expenses. For instance, in Canada, there is
    limited fund for IVF and intracytoplasmic sperm
    injection and hence infertile couples have to
    bear the cost of treatment. The average cost for
    infertility treatment in Canada is quite
    expensive and ranges from between US 10,000 to
    US 20,000.
  • Moreover, infertility treatments may not prove to
    be conclusive or effective and thereby need to be
    repeated sometimes. Such a risk of repetition of
    procedures negatively affects the decision of the
    consumers and limits market growth

6
Human Reproductive Technologies Market Report
Coverage

7
Global Human Reproductive Technologies Market
Opportunities
  • Increasing rate of literacy is expected to offer
    lucrative growth opportunities for players in the
    global human reproductive technologies market.
    For instance, according to United Nations
    Children's Fund, globally, the youth literacy
    rate increased from 83 to 91 during 1985-2018.
  • Moreover, RD in male birth control pill is also
    expected to aid in growth of the market. For
    instance, in March 2018, researchers from the
    University of Washington presented positive
    results from a small clinical trial of 100 men
    for a male birth control pill that inhibits
    testosterone production.
  • The global human reproductive technologies market
    was valued at US 28,426.7 Mn in 2019 and is
    forecast to reach a value of US 34,228.3 Mn by
    2027 at a CAGR of 2.4 between 2020 and 2027.

8
Figure 2. Global Human Reproductive Technologies
Market Value (US Bn), and Y-o-Y Growth (),
2019-2027

9
  • Market Trends/Key Takeaways
  • Increasing population is expected to propel
    demand for emergency human reproductive
    technologies. For instance, according to
    projections by Population Reference Bureau (PRB)
    included in the 2018 World Population Data Sheet,
    the world population is expected to reach 9.9
    billion by 2050, up 2.3 billion or 29 from an
    estimated 7.6 billion people in 2018.
  • However, low adoption of emergency human
    reproductive technologies in emerging economies
    is expected to act as a drag for the demand. For
    instance, according to PRBs 2019 Family Planning
    Data Sheet, fewer than 15 of married women of
    reproductive age use a modern human reproductive
    technologies in Democratic Republic of the Congo.

10
Global Human Reproductive Technologies Market
Competitive Landscape
  • Major players operating in the global human
    reproductive technologies include, Abbott
    Laboratories, Evofem Biosciences, Inc., Actavis
    Generics (Teva Pharmaceutical Industries Ltd.),
    Sun Pharmaceutical Industries Ltd., Perrigo
    Company plc, Uniprix, Gavis Pharmaceuticals
    (Lupin Limited), Sandoz International GmbH,
    Aurobindo Pharma Limited, HRA Pharma, SA, Mankind
    Pharma, Cryos USA, Merck Co, Bayer HealthCare
    AG, Church Dwight, Co. Inc., Allergan, Pfizer,
    Inc., Agile Therapeutics Inc., BioSante
    Pharmaceuticals Inc., Mayer Laboratories, Inc.,
    Pantarhei Bioscience B.V., Cook Medical, Inc.,
    Ferring Pharmaceuticals, Johnson Johnson, Daré
    Bioscience, Inc., and Merck Serono.

11
Global Human Reproductive Technologies Market
Key Developments
  • Major players in the market are focused on
    approval and launch of new products to expand
    their product portfolio. For instance, in May
    2020, Evofem Biosciences, Inc. received the U.S.
    Food and Drug Administration (FDA) approval for
    Phexxi (lactic acid, citric acid and potassium
    bitartrate) vaginal gel used to prevent pregnancy
    in females of reproductive potential for use as
    an on-demand method of contraception.
  • Major players in the market are also focused on
    adopting partnership strategies to expand their
    product portfolio. For instance, in May 2020,
    Daré Bioscience, Inc., a developer of womens
    health solutions partnered with Health Decisions,
    Inc., a full-service contract research
    organization (CRO) specializing in womens health
    clinical research and diagnostic development,
    under which Health Decisions will exclusively
    provide CRO services within the U.S. to support
    RD of Darés pipeline of contraception,
    fertility, and gynecological disorders products.

12
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//www.coherentmarketinsights.com/
    market-insight/human-reproductive-technologies-mar
    ket-3921

13
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

14
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

15
Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
About PowerShow.com